http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006060477-A9

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdd619b8a2cc2f110b9ee4dc8d896a17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_270d22c3c4d9246708415366197142d2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-1613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-164
filingDate 2005-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0be28e2e746e8dca20c256c4232b7da1
publicationDate 2006-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006060477-A9
titleOfInvention Contrast-enhancing aspheric intraocular lens
abstract The present inventions provides an intraocular lens (IOL) having an optic with a posterior and an anterior refractive surfaces, at least one of which has an aspherical profile, typically characterized by a non-zero conic constant, for controlling the aberrations of a patient’s eye in which the IOL is implanted. Preferably, the IOL’s asphericity, together with the aberrations of the patient’s eye, cooperate to provide an image contrast characterized by a calculated modulation transfer function (MTF) of at least about o.25 and a depth of field of at least about o.75 diopters.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8974526-B2
priorityDate 2004-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6581

Total number of triples: 17.